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Introduction
The monoclonal character of proliferating smooth muscle cells in human atherosclerotic plaques (1 -4) is analogous to that observed in uterine leiomyomas (5, 6) and suggests a neoplastic genre for the atheromatous lesions. Indeed, several reports from independent laboratories (7 -9) have established that two carcinogenic chemicals, 7,12-dimethylbenz[a]anthracene (DMBA)* and benzo [a] pyrene (B[a]P) are capable of enhancing the development of atheromatous lesions in an avian species. The mechanism(s) whereby these promutagenic/procarcinogenic substances elicit atherogenic effects has not been ascertained but analogies between atheromatous lesions and neoplastic lesions (3, 10, 11) as well as the lack of biologic activity of the parent chemicals lead to the presentiment that the hydrocarbons may also be proatherogenic; e.g., may require metabolic biotransformation to electrophilic intermediates in order to exhibit atherogenic effects.
During investigations of the relationships between the biotransformation/bioactivation of polynuclear aromatic hydrocarbons (PAH) and their carcinogenic effects, it was found that an apparent relationship existed between the susceptibility of certain mouse strains to develop neoplasms as a result of exposure to PAH and the inducibilty of cytochrome P-450-dependent monooxygenases that catalyze the conversion of the inactive PAH to proximate mutagenic and carcinogenic forms (12 -17) . Since previous investigations (18 -22) had demonstrated that aortas of avian and other species contain the necessary enzymes for catalysis of the monooxygenation of B[a]P and DMBA, we wished to investigate aortic and hepatic monooxygenases and their susceptibility to induction in two avian strains that differ in thenpropensity to develop spontaneous aortic atherosclerosis. Atherosclerosis-susceptible White Carneau (WC-2) pigeons develop severe, grossly observable aortic lesions by 3 yr of age whereas Show Racer (SR-39) pigeons are relatively resistant to aortic atherosclerosis (23 -25) . Although differences in energy and lipid metabolism have been documented in these two strains (26, 27) , additional factors almost certainly operate during early atherogenesis of which little is understood. We therefore have compared B[a]P metabolism in aortic target and hepatic tissues from untreated and 3-methylcholanthrene (MQ-pretreated WC-2 and SR-39 pigeons. Profiles of organic solvent-extractable metabolites were analyzed with h.p.l.c. and inducibility of the P-450-dependent monooxygenases was compared. In addition, a comparison of the inducibility of monooxygenases in aortas from WC-2 pigeons of 6-12 months versus 2-5 yr of age was made. Finally, the capacity for conversion of the PAH to products mutagenic and cytotoxic for Salmonella typhimurium (TA 1538) was compared in the two pigeon strains.
Materials and Methods

Experimental animals
WC-2 and SR-39 pigeons were obtained from the Research Farm at Bowman-Gray School of Medicine, Winston-Salem, NC, and allowed to acclimate for 3 -5 days. Normal pigeon food (Purina) and water were given ad libitum. Pigeons were housed two per cage in an artificially lighted room where the lights were turned on and off at regular 12 h intervals. For experiments designed to test the effects of inducing doses of MC on hepatic and aortic monooxygenase activities, pigeons of each strain were divided randomly into two groups. Pigeons in one group received a single i.p. injection of MC (40 mg/kg) in corn oil. Control pigeons received an equivalent volume of vehicle. Forty eight hours after the injections, the birds were killed by decapitation. Separate groups of pigeons were utilized in experiments in which Aroclor 1254 (a mixture of polychlorinated biphenyl compounds) was employed as the monooxygenase inducer. Pigeons were injected i.p. with a single dose of Aroclor 1254 (500 mg/kg) and killed 5 days later. Aortas and livers from all groups were rapidly excised, cleaned of adhering fatty and connective tissue and placed in ice-cold 0.15 M KC1/0.1 M potassium phosphate buffer at pH 7.35. Hepatic tissues were homogenized in 3 volumes of the buffer solution with a teflon-glass homogenizer. Homogenates were centrifuged at 9000 x g for 20 min; the supernatant fractions (S-9) were decanted and frozen at -80°C. Enzyme activities were stable for at least one month under these storage conditions and all assays were performed within 10 days. Aortic tissues were homogenized in 4 volumes of the buffer solution with a Polytron PT-10 homogenizer (Brinkmann Instruments) for 1 min at a setting of 6. The resulting homogenate was utilized as the source of aortic enzymes for all subsequent studies. The homogenate was stored at -80°C and the aortic enzymes were stable under these storage conditions for at least one month. All preparations were assayed within 10 days. and eluted with a methanol:water (80-100% methanol) linear gradient (4 ml/min; 30 min). Greater than 99% purity was achieved with this technique. Glucose 6-phosphate dehydrogenase, NADPH, NADP, NADH and glucose 6-phosphate were obtained from the Sigma Chemical Co., St. Louis, MO. All other chemicals utilized were reagent grade and of the highest purity available through commercial suppliers. Sources for the metabolite standards used in these studies were the same as described previously (19, 28) as well as from the Chemical Repository of the National Cancer Institute.
Chemicals
Incubation conditions for enzyme assays
Incubation flasks contained final concentrations of B[a]P (2.7 jiM),
[a]P (0.5 ,*Ci), NADPH (1 mM), NADH (0.7 mM), glucose 6-phosphate (2.5 mM), aortic whole homogenate (1 -2 mg protein) or hepatic S-9 (30 -50 /ig protein from MC-treated pigeons and 150-200 \>% protein from control pigeons) and potassium phosphate buffer (0.05 M, pH 7.35) in a total volume of 1.0 ml. Preliminary experiments indicated that substrate concentrations were not rate-limiting. Incubations were carried out in the dark under an atmosphere of -100% oxygen at 37°C and with constant shaking in a Dubnoff incubator. Aortic preparations were incubated for 1 h; hepatic preparations from MC-treated animals for 5 min and hepatic preparations from controls for 15 min. All reactions were linear with time and protein concentrations under these conditions. The reactions were stopped by adding 4 ml of ice-cold hexane:acetone (4:1) to each incubation tube. The tubes were further incubated with shaking for an additional 10 min. They were then centrifuged at low speed for 5 min and the organic phase was removed and pooled with extracts from duplicate incubation flasks. Four ml of ethyl acetate:acetone (2:1) were added to the aqueous phase and the mixture was shaken and centrifuged as before. The organic phase from the second extraction was pooled with that from the first extraction and evaporated to dryness under a gentle stream of nitrogen in the dark. Extracts were redissolved in 0. (Table I) , were compared with the other standards in separate experiments. The B[a]P-derivatives listed above were included as internal standards in every h.p.l.c. run. Typical retention times for all standards utilized are presented in Table I . a Each h.p.l.c. system is described in detail in Materials and Methods.
b Not known to be a metabolite of B[a]P.
pie (with added standards) were injected onto the column at 30°C and eluted with a linear, 35-min, water-methanol gradient (1.5 ml/min; 60-80% methanol). Individual fractions were collected at 24-s intervals for the first 30 min and then 36 s intervals for an additional 15 min.
For system 2, a Whatman Partisil 10/25 ODS-2 column (4.6 mm I.D. x 25 cm) was employed. Ten pi of sample were injected onto the column at 30°C as described above and eluted with a linear, 30-min, water-methanol gradient (1.0 ml/min; 80-100% methanol). Fractions were collected at 24-s intervals for the first 30 min and then 1-min intervals for an additional 15 min.
For system 3, a Whatman Partisil 10/25 ODS column (4.6 mm I.D. x 25 cm) was used. Ten /A of sample were eluted at 30°C with a linear water-methanol gradient (1.0 ml/min; 50-100% methanol). Fractions were collected at 18-s intervals for 30 min.
For each system, cold standards were monitored concomitantly with each assay by u.v. absorption and retention times of eluted standards were matched to retention times of the radioactive materials eluting from the columns. Tritiated B[a]P and "C-labeled B[a]P yielded identical h.p.l.c. profiles in all experiments in which the two were compared. B[a]P-4,5-oxide was stable in each of the h.p.l.c. systems utilized.
Liquid scintillation counting
Aquasol II LSC cocktail (New England Nuclear) was added to collected fractions and scintillation counting was performed in Beckman LS 8000 and LS 9000 liquid scintillation counters. Digital output from the LS 8000 was recorded on cassette tapes using write-and-read-interface units (Meditek Labs., Seattle, WA) and data reduction was performed on an HP 9830 A computer/ plotter. Standard quench curves were computed using [ 
Mutagenesis assays
Bacterial mutagenesis was performed according to slight modifications of the method of Ames (29) using tester strain TA 1538 and sterile hepatic S-9 or aortic homogenates from WC-2 and SR-39 pigeons. NADP (4 mM), glucose 6-phosphate (5 mM) and B[a]P in varying concentrations (0.3 -1.3 /ig/plate) were added to 10 x 35 mm Petri dishes. Duplicate test plates and four separate duplicate controls were utilized for each experiment: heat-inactivated (100°C, 10 min) S-9, an enzyme blank, a B[a]P blank, and a blank containing neither enzyme nor hydrocarbon. Numbers of background colonies appearing Table I . Radioactivity eluting with 7-hydroxy-B[a]P was attributable primarily to B[a]P-l,6-dione; thus the peak is labeled as the dione. Under the reaction conditions utilized, quantitites of radioactive material remaining in the aqueous phase were less than 1% of that added to the reaction vessels. Radioactivity eluting in fractions 7 -13 did not co-chromatograph with any of the standards utilized. Results H.p.l.c. profiles (system 2) of organic solvent-extractable metabolites generated by preparations of hepatic and aortic tissues from WC-2 and SR-39 pigeons are presented in Figures 1 and 2 , respectively. Of interest was the appearance of relatively large quantities of metabolites that coeluted with 7-hydroxy-B[a]P, B[a]P-4,5-oxide and B[a]P-4,5-diol. With the separations attainable in h.p.l.c. system 2 it originally appeared that these were major metabolites generated when either hepatic or aortic preparations of pigeons were utilized as enzyme sources. The radioactive peak eluting with 7-hydroxy-B[a]P did not coincide with the 9-hydroxy-B[a]P standard in system 2 but was found to coelute with B[a]P-l,6-dione in the same system (Table I) . Subsequent utilization of system 1 demonstrated that the radioactive peak was attributable largely to the dione rather than the phenol. Examination of the profile with system 3 was also consistent with the latter interpretation. Utilization of the 3 h.p.l.c. systems in combination was also useful in sorting out the contributions of various other co-chromatographing metabolites. For example, in system 1, the 1-, 3-and 7-hydroxy metabolites all eluted under the same peak. Rechromatography of fractions collected under that peak after injection into systems 2 or 3 indicated that most of the radioactivity was attributable to the 3-hydroxy metabolite. This could be further tested by subjecting fractions collected to fluorimetric analyses. Collection of fractions corresponding with the 3-hydroxy peak in system 1 and subsequent analyses of fluorimetric spectral scans indicated that most of the material eluting under the peak was attributable to 3-hydroxy-B[a]P. However, presence of the 1-hydroxy metabolite eluting with 3-hydroxy B[a]P could not be entirely ruled out due to similarities in retention times in all systems and in the fluorometric spectra.
In repeated experiments it could be shown that the WC-2 pigeons were considerably more susceptible to induction of the microsomal monooxygenase systems by MC both in the liver (Table II) and the aorta (data not shown). In hepatic systems of the WC-2 strain, the most pronounced increases elicited by MC were observed in the fractions co-chromatographing with B[a]P-4,5-diol (systems 1 and 2); but very large increases were also noted in every peak. In hepatic systems of the SR-39 strain, the largest increases were observed in the fractions co-eluting with B[a]P-4,5-oxide. The 4,5-oxide peak partially overlapped with the 9-hydroxy peak in system 2 but an examination of the profile with system 1 indicated that at least 70% of the radioactivity was attributable to the arene oxide in both the controls and inducer-treated birds, suggesting approximately equal induction with respect to the two positions on the B[a]P molecule. It was of interest that increases in quantitites of the 4,5-oxide produced in hepatic preparations by pretreatment with MC were similar in both strains. Thus in hepatic tissues of pigeons, oxidation at the K-region would appear to be the most susceptible to regulation via induction by MC-type inducing agents. Studies in other strains may be needed to establish this point more fully. Pretreatment of pigeons with Aroclor 1254 resulted in profile changes (data not shown) that were very similar to those produced by treatment with MC and further substantiated the inducibility differences.
In repeated experiments with aortic tissues of the WC-2 strain, pretreatment with MC produced the largest increases (-12-fold) in the fraction that co-chromatographed with c In this system (System 2) it was estimated that -30% of the radioactivity eluting with the 4,5-oxide was attributable to the 9-hydroxy metabolite. B[a]P-9,10-diol. Large increases (3-8-fold) were also observed in all other peak fractions. In aortic tissues of MC-pretreated SR-39 pigeons, however, either only very minor increases (B[a]P-4,5-oxide, 2-fold, and B[a]P-l,6-dione 1.5-fold), no detectable changes (B[a]P-9,10-diol and 3-hydroxy-B[a]P), or even 40% decreases (B[a]P-4,5-diol and B[a]P-l,6-dione) were observed. It should be noted that basal levels of enzymic activities were slightly higher in the SR-39 strain than in the WC-2 strain. As with hepatic preparations, aortic preparations of the WC-2 strain exhibited a much greater inducibility than did those of the SR-39 strain. This was particularly evident in young pigeons. Aortic tissues from WC-2 pigeons aged 6-12 months exhibited 3-12-fold inducibility whereas aortic tissues form the same strain at 2 -5 yr of age exhibited only very minor (maximum of 3.3-fold) and, for the most part, statistically insignificant increases. No age differences in inducibilty could be detected in the SR-39 strain. Identities of the eluted metabolites were further substantiated by collecting the fractions eluting with cochromatographing metabolites in one system, and reinjecting the fractions into a second system. This procedure provided further evidence that the B[a]P-4,5-oxide was a major metabolite produced by aortic tissues in both avian strains.
In experiments designed to examine differences in the capacity of the hepatic and aortic tissues from the two pigeon strains to convert B[a]P to mutagenic and/or cytotoxic intermediates, we observed only minor differences between the untreated pigeons. However, after pretreatment with MC, hepatic preparations from the WC-2 strain exhibited a very marked increase (9-fold at 50 ng S-9 protein) in capacity to generate mutagens (Figure 3) . The SR-39 strain also exhibited an increase following MC pretreatment but the capacity was lower than that observed in the WC-2 strain. No differences in capacity of the preparations to generate cytotoxic intermediates could be detected (data not shown). The cytotoxicity elicited was minimal in all cases, even at the highest B[a]P (12.5 jig/plate) and protein (100 /ig/plate) concentrations. Pigeon aortic preparations did not generate statistically significant levels of mutagenic or cytotoxic intermediates with the systems employed, probably because of their much lower capacity for B[a]P metabolism.
Discussion
Treatment of white leghorn chickens with polynuclear aromatic hydrocarbons (B[a]P or DMBA) results in an enhanced development of atherosclerotic lesions of the same morphologic type as is commonly observed in human aortas (7) (8) (9) . In view of the similarities observed between benign smooth muscle tumors of the uterus (leiomyomas) and the human and avian atherosclerotic lesions (also characterized by apparently benign proliferations of smooth muscle cells), we deemed it important to select strains of an avian species that were differentially susceptible to athcrogenesis. The White Carneau and Show Racer strains have long been utilized in atherosclerosis research because of their differing propensity to develop aortic atherosclerosis (23) (24) (25) . The research reported here has demonstrated marked differences in the responses of these two pigeon strains to induction of both hepatic and aortic monooxygenase systems by inducers of the MC-type. It will now be of considerable interest to determine whether the differences in inducibility of enzymes responsible for biotransformation of PAH will also be reflected in differences between the two strains in susceptibility to PAH-elicited atheromatous lesions. On the basis of the results obtained in our studies, we would expect that the WC-2 strain would be more susceptible to PAH-mediated atherogenesis than the SR-39 strain and we have now initiated investigations in attempts to determine whether or not this expectation is valid. If so, this could be a potentially valuable tool in the exploration of the mechanisms by which PAH influence the development of atherosclerotic lesions and of the role of PAH-biotransformation and bioactivation in such processes. It is of interest that greater strain differences in in-ducibility were manifest in aortic tissues than in hepatic tissues from the same birds. Whether this is a function of the tissue preparation employed or represents an important tissue-specific difference remains to be ascertained.
The importance of bioactivation of proatherogenic chemicals by target organs and target cells requires investigation in each affected tissue. Whether the target organs/cells are more important than the liver -the principal site of biotransformation -for bioactivation would, expectedly, depend on the stability of the ultimate atherogenic intermediate. In terms of PAH-elicited atherogenesis, such an intermediates) remains unidentified at present but it is of interest that we have shown that cultured aortic smooth muscle cells will catalyze the putative bioactivating reaction(s) (31) and that the monooxygenases are inducible in these cells.
Regardless of the ultimate mechanism by which PAH exerts atherogenic effects, it seems logical to suppose that reactive intermediary metabolites of these chemicals are the proximate atherogenic or co-atherogenic agents since the parent compounds are relatively inert both chemically and biologically. Thus bioactivation and inactivation (and regulatory control of these processes) may be presumed to play extremely important roles in their atherogenic properties. Bioactivated chemicals vary in their stability/reactivity according to four general categories: (i) those which are extremely unstable and can persist only at the immediate site (enzyme) of bioactivation (examples are metabolites of 'suicide substrates' such as allylisopropylacetamide), (ii) those which persist only within the cells in which bioactivation occurs, (iii) those which persist primarily only within the tissues in which bioactivation occurs (not sufficiently stable to persist in the circulation) and (iv) those capable of being transferred in the circulation from one organ to another. For three of these four categories, biotransformation in the aorta per se (target tissue activation) would be of prime interest and importance.
Numerous theories of atherogenesis have been proposed. Some authorities have emphasized the role of hyperlipidemia and of lipid infiltration into the arterial wall. Others have pointed to the part played by connective tissue changes in response to various kinds of injuries. Yet other theories have been connected with structural, metabolic or hormonallyinduced changes within the arterial wall. The widespread recognition that proliferation of arterial wall smooth muscle cells situated in the intima is a very early feature in the formation of an atheroma, and resultant investigations into the causes of such cellular proliferation, has led to a recent hypothesis referred to as the 'monoclonal theory' and is based upon analyses of human plaques obtained at autopsies (1, 2, 32) . It was discovered that the cells obtained from single plaques in the arterial walls of black females (heterozygotes for forms A and B of glucose 6-phosphate dehydrogenase) expressed only one or the other of the two forms of the enzyme while the surrounding, non-plaque tissue expressed both forms. The results of these experiments were later confirmed in independent investigations (3, 33) and are compatible with the interpretation of the cellular proliferation as monoclonal. Elimination of cells with one form of the enzyme within plaques via selection seemed unlikely since plaques exhibiting both A and B monotypes could be found in the same aorta. It seemed likely that a genetic (mutation) or epigenetic event originally resulted in a selective growth advantage for a single precursor smooth muscle cell or cells and their progeny. This process would be analogous to that proposed for the initiation and development of neoplastic tumors (34) . It is now recognized that certain tumors (35, 36) as well as certain atheromas (4, 37) are of multicellular origin. However, the inference is that at least some of the lesions are monoclonal and thus could have been provoked to evolve as the result of a mutagenic stimulus. Of course, lesions of multicellular origin also could be envisioned as resultants of multiple mutations caused by a more powerful mutagenic stimulus. Of special interest is the exhibition of apparent monoclonality by benign, smooth-muscle tumors (leiomyomas) of the uterus (5) .
The implications of the monoclonal theory for the role of environmental mutagens/promutagens and carcinogens/procarcinogens in atherosclerosis are immediately obvious. These agents appear to be responsible for a very high percentage of the malignant tumors that occur in human populations (38, 39) . Probably, the most common of currently prevalent environmental contaminants, are the PAH (40), many of which are known to be promutagens and procarcinogens. Thus, it seems to be of considerable importance to elucidate mechanisms whereby the PAH enhance the formation of atheromatous lesions.
